Hotel Tonight To Be Acquired by Airbnb
March 7, 2019 San Francisco, CA – Hotel Tonight announced today that it is to be acquired by AirBNB to expand the mobile home-sharing company’s hotel and travel offerings. FLG partner, Laureen DeBuono assisted Hotel Tonight as its Interim CFO to get the deal negotiated and executed. Read more here.
Read MoreOyster Point Raises $93 Million for Phase 3 Trials of Novel Treatment for Dry Eye Disease
PRINCETON, N.J., February 26, 2019 – FLG Partner’s client, Oyster Point Pharma, Inc., a privately held clinical-stage pharmaceutical company has announced a $93 million Series B financing. The round was co-led by Invus Opportunities and Flying L Partners in collaboration with Falcon Vision. Existing investors New Enterprise Associates (NEA) and…Read More
Read MorePerfectServe Acquires Lightning Bolt
Feb. 5, 2019 — PerfectServe, a leading provider of cloud-based clinical communication and collaboration (CC&C) solutions, today announced the acquisition of FLG Partner client, Lightning Bolt Solutions, an AI-optimized physician shift scheduling technology for hospitals and health systems. The acquisition was announced, in tandem, with the acquisition of CareWire, a mobile patient…Read More
Read MoreCortexyme Announces Key Leadership Appointments to Support Next Stage of Growth
FLG client, Cortexyme, a privately held, clinical-stage pharmaceutical company developing therapeutics to alter the course of Alzheimer’s disease (AD) and other degenerative disorders, announced effective January 2019, two key leadership appointments. Veteran clinical development professional Michael Detke, M.D., Ph.D., has been appointed Chief Medical Officer and Chris Lowe, a longtime…Read More
Read MoreSoleno Therapeutics Announces $16.5 Million Private Placement
REDWOOD CITY, Calif., Dec. 19, 2018 (GLOBE NEWSWIRE) — FLG client, Soleno Therapeutics, Inc. (NASDAQ: SLNO), a clinical-stage biopharmaceutical company developing novel therapeutics for the treatment of rare diseases, today announced that it has entered into a definitive agreement with certain institutional and accredited investors to raise aggregate gross proceeds…Read More
Read More